menu
    • menu

    Company profile for Revalesio

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies address cellular imbalances related to mitochondrial dysfunction and thereby modulate the immune response. They have been shown to protect neurons in models of chronic neurological diseases and improve recovery in acute neurological injury. We ar...
    Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies address cellular imbalances related to mitochondrial dysfunction and thereby modulate the immune response. They have been shown to protect neurons in models of chronic neurological diseases and improve recovery in acute neurological injury. We are partnering with internationally renowned scientists in biomedical research in a concerted effort to improve the lives of millions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RevalesioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1202-1204 E D St Tacoma, WA 98421
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://revalesio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revalesio-corporation/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Revalesio Unveils RNS60 Stroke Advances at ASENT Meeting
    Revalesio Unveils RNS60 Stroke Advances at ASENT Meeting

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-to-present-advances-in-stroke-treatment-with-rns60-at-the-american-society-for-experimental-neurotherapeutics-asent-annual-meeting-302704695.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    Revalesio To Showcase Rns60's Hospital Stay Reduction Potential
    Revalesio To Showcase Rns60's Hospital Stay Reduction Potential

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-to-present-findings-from-a-post-hoc-analysis-of-phase-2-rescue-trial-at-svin-2025-highlighting-rns60s-potential-to-shorten-hospital-stay-302619619.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Revalesio To Unveil RNS60 Data From RESCUE Trial At World Stroke
    Revalesio To Unveil RNS60 Data From RESCUE Trial At World Stroke

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-to-present-rns60-12-hour-data-from-the-phase-2-rescue-trial-in-acute-ischemic-stroke-at-world-stroke-congress-2025-302589710.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    FDA Fast Tracks Revalesio's RNS60 for Ischemic Stroke Treatment
    FDA Fast Tracks Revalesio's RNS60 for Ischemic Stroke Treatment

    31 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-receives-fda-fast-track-designation-for-rns60-for-the-treatment-of-acute-ischemic-stroke-302517694.html

    PR NEWSWIRE
    31 Jul 2025
    Share Share
    Revalesio Publishes Ph 2 Results for RNS60 in Acute Ischemic
    Revalesio Publishes Ph 2 Results for RNS60 in Acute Ischemic

    21 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-announces-publication-of-rescue-phase-2-trial-results-evaluating-rns60-as-an-adjunctive-therapy-for-acute-ischemic-stroke-in-the-journal-stroke-302509320.html

    PR NEWSWIRE
    21 Jul 2025
    Share Share
    Revalesio to Present RNS60 Phase 3 Stroke Trial Design
    Revalesio to Present RNS60 Phase 3 Stroke Trial Design

    14 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revalesio-to-present-phase-3-trial-design-and-post-hoc-analysis-of-phase-2-rescue-trial-of-rns60-in-acute-ischemic-stroke-at-the-snis-22nd-annual-meeting-302503947.html

    PR NEWSWIRE
    14 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search